SCHEMBL7954447

SCHEMBL7954447

CC(C)(C)[Si](OCc1nc2c([N+](=O)[O-])cccc2[nH]1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.42
PKN2 Q16513 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
ITGB3 P05106 1/20 0.37
ITGAV P06756 1/20 0.37
KCNJ1 P48048 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
DRD4 P21917 1/20 0.34
ABL1 P00519 1/20 0.34
RIPK1 Q13546 1/20 0.34
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 2/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7485939 0.81 CHEK1 (0.46) GAAMEN1KMT2AALDH1A1MAPT
SCHEMBL7568707 0.80 KDM4E (0.46) KDM4ECYP1A2CYP2C9
SCHEMBL7475180 0.79 PKN1 (0.51) PKN1PKN2ADORA3GAAMGAM
SCHEMBL7480003 0.77 RIPK1 (0.47) PKN1PKN2RIPK1ALDH1A1KDM4E
SCHEMBL18663648 0.77 CBFB (0.40) MEN1KMT2AMAPTCYP1A2NPC1
SCHEMBL8598342 0.74 GAA (0.56) PKN1PKN2ADORA3GAAMGAM
SCHEMBL6995989 0.74 PKN1 (0.57) PKN1PKN2ADORA3GAAMGAM
SCHEMBL15979557 0.74 ABL1 (0.43) MEN1KMT2AABL1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL4882337 0.73 PKN1 (0.53) PKN1PKN2ADORA3GAAMGAM
SCHEMBL6537647 0.72 ALDH1A1 (0.42) GAAMEN1KMT2AABL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed